Marshall Keith W
Chief Financial Officer at Prometheus Biosciences, Inc.
- Sold, on record
- $3.5M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Apr 5, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Prometheus Biosciences, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Prometheus Biosciences, Inc.UnusualJan 17, 2023 2023
Sold 5,000 shares at $119.00 ($595k)
Marshall Keith W, Chief Financial Officer
Sold 33.8% of holdings ($1.8M position)9,811 shares leftFirst sale on recordFiling
- 2 Form 4 sale Prometheus Biosciences, Inc.UnusualFeb 15, 2023 +29 days
Sold 5,000 shares at $119.38 ($597k)
Marshall Keith W, Chief Financial Officer
Sold 33.8% of holdings ($1.8M position)9,811 shares leftFiling
- 3 Form 4 sale Prometheus Biosciences, Inc.UnusualMar 6, 2023 +19 days
Sold 10,000 shares at $122.13 ($1.2M)
Marshall Keith W, Chief Financial Officer
Sold 50.5% of holdings ($2.4M position)9,811 shares leftFiling
- 4 Form 4 sale Prometheus Biosciences, Inc.UnusualApr 5, 2023 +30 days
Sold 10,000 shares at $108.42 ($1.1M)
Marshall Keith W, Chief Financial Officer
No 10b5-1 planSold 50.5% of holdings ($2.1M position)9,811 shares left2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Apr 7, 2023 | Prometheus Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $1.1M | 50.5% | Unusual | SEC |
| Mar 6, 2023 | Mar 8, 2023 | Prometheus Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $1.2M | 50.5% | Unusual | SEC |
| Feb 15, 2023 | Feb 17, 2023 | Prometheus Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 5,000 | $597k | 33.8% | Unusual | SEC |
| Jan 17, 2023 | Jan 19, 2023 | Prometheus Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 5,000 | $595k | 33.8% | Unusual | SEC |